Forte Biosciences (FBRX) EBT Margin (2017 - 2019)
Forte Biosciences' EBT Margin was -117588.89% in Q4 2019, up 98122.22 percentage points from -215711.11% a year earlier and up 90577.78 percentage points from the prior quarter.
Powered by 
Analysis
Forte Biosciences (FBRX) EBT Margin (2017 - 2019) Analysis & Trends
For FY2019, EBT Margin at Forte Biosciences came in at -176430.56%, down 176168.55 percentage points from FY2018.
- EBT Margin shows a three-year change of -108110.15 percentage points (FY2016 to FY2019).
- In earlier years, EBT Margin was -262.01% in FY2018 (+94684.33 pp), -94946.34% in FY2017 (-26625.93 pp) and -68320.41% in FY2016.
- Quarterly EBT Margin has moved between -215711.11% (Q4 2018) and 6.25% (Q3 2018) over five years.
- Compared with a year earlier, EBT Margin was higher in three of the last seven quarters, with an average year-over-year change of -12062.54 percentage points.
- Per Business Quant data, FBRX's EBT Margin in the three quarters before Q4 2019 was -208166.67% (Q3 2019), -10311.11% (Q2 2019) and -189822.22% (Q1 2019).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Forte Biosciences | 1.58 Bn | 1.38 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | -117,588.89% |
| Sep 30, 2019 | -208,166.67% |
| Jun 30, 2019 | -10,311.11% |
| Mar 31, 2019 | -189,822.22% |
| Dec 31, 2018 | -215,711.11% |
| Sep 30, 2018 | 6.25% |
| Jun 30, 2018 | -178,766.67% |
| Mar 31, 2018 | -143,111.11% |
| Dec 31, 2017 | -108,370.00% |
| Sep 30, 2017 | -99,530.00% |
| Jun 30, 2017 | -90,440.00% |
API Access
Forte Biosciences EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=FBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "FBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=FBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();